Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms

Area of Science:

• Immunology
• Reproductive Biology
• Cell Biology

Background:

• Platelets are implicated in endometriosis development.
• Platelet-derived transforming growth factor-β1 (TGF-β1) is known to suppress NK Group 2, Member D (NKG2D) expression on NK cells, reducing their cytotoxicity in endometriosis.
• The precise mechanisms by which platelets affect NK cell function in endometriosis remain under investigation.

Purpose of the Study:

• To investigate the role of platelets in the reduced cytotoxicity of natural killer (NK) cells in endometriosis.
• To elucidate the mechanisms by which platelets impair NK cell function in the context of endometriosis.

Main Methods:

• Experiments involved mice with induced endometriosis, with depletion of platelets, NK cells, or both.
• In vitro studies utilized NK cells, platelets, and endometriotic cell lines.
• Assays included immunohistochemistry, immunofluorescence, flow cytometry, gene expression analysis, cytotoxicity assays, and measurement of cytokine secretion.

Main Results:

• Platelet depletion significantly reduced endometriosis lesion weight in mice, suggesting enhanced NK cell cytotoxicity against endometriotic cells.
• Platelets coated target cells, increasing MHC-I expression and reducing NK cell-mediated lysis.
• Platelets impaired NK cell cytotoxicity by reducing degranulation, IFN-γ production, and expression of activating receptors (NKG2D, NKp46), while increasing inhibitory receptor (KIR2DL1) expression, partly via TGF-β1 signaling.

Conclusions:

• Platelets impair NK cell reactivity and function in endometriosis through multiple mechanisms, including TGF-β1-mediated suppression of NKG2D.
• Targeting platelets may represent a novel therapeutic approach for endometriosis by enhancing NK cell-mediated anti-endometriotic effects.